Efficacy and Safety Study of 610 in Patients With Severe Asthma
Clinical trial NCT06323213 · RECRUITING
Trial details
- NCT number
- NCT06323213
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2027-02-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.